cyclophosphamide,nab-paclitaxel
immunitybio
[]
$ibrx immunitybio announces presentation at asco gi 2023 of fully enrolled trial in third-line and greater pancreatic cancer and update on fda type b meetings regarding paths to registration 
This is an automated account sharing new press releases in real time from https://t.co/7iCFuj68H6